These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


126 related items for PubMed ID: 7894967

  • 1. Interferon therapy in hepatitis C.
    Zein NN, Rakela J.
    Semin Gastrointest Dis; 1995 Jan; 6(1):46-53. PubMed ID: 7894967
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Parameters predicting response to alpha-interferon treatment in chronic hepatitis C.
    Glück T, Seelig R, Dette S, Bühring HJ, Renz M, Kwon S, Wiedmann KH, Weber P.
    Hepatogastroenterology; 1997 Jan; 44(14):484-91. PubMed ID: 9164523
    [Abstract] [Full Text] [Related]

  • 4. Hepatic expression of hepatitis C virus RNA in chronic hepatitis C: a study by in situ reverse-transcription polymerase chain reaction.
    Lau GK, Davis GL, Wu SP, Gish RG, Balart LA, Lau JY.
    Hepatology; 1996 Jun; 23(6):1318-23. PubMed ID: 8675145
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. alpha-Interferon retreatment of patients with chronic hepatitis C.
    Rabinovitz M, Block G, Finkelstein SD.
    Am J Gastroenterol; 1996 Aug; 91(8):1523-6. PubMed ID: 8759654
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Therapy of active chronic hepatitis with recombinant alpha 2b-interferon: an 18 month follow-up.
    Bresci G, Parisi G, Banti S, Bertoni M.
    Eur J Med; 1993 Aug; 2(6):349-52. PubMed ID: 8252180
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Interferon therapy for chronic hepatitis C.
    Davis GL.
    Baillieres Clin Gastroenterol; 1996 Jul; 10(2):289-98. PubMed ID: 8864035
    [Abstract] [Full Text] [Related]

  • 13. Treatment of chronic hepatitis C with interferon alfa-n3: a multicenter, randomized, open-label trial.
    Simon DM, Gordon SC, Kaplan MM, Koff RS, Regenstein F, Everson G, Lee YM, Weiner F, Silverman A, Plasse T, Fedorczyk D, Liao MJ.
    Hepatology; 1997 Feb; 25(2):445-8. PubMed ID: 9021962
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Prognostic relevance of hepatitis C virus genotype for responsiveness to interferon-alpha].
    Berg T, König V, Küther S, Heuft HG, Wittmann G, Lobeck H, Hopf U.
    Z Gastroenterol; 1995 Aug; 33(8):426-30. PubMed ID: 7483733
    [Abstract] [Full Text] [Related]

  • 16. Recombinant human interferon alpha-2a therapy for chronic hepatitis C with or without cirrhosis: comparison of 3 or 6 MU for 1 year.
    Caporaso N, Suozzo R, Morisco F, D'Antonio M, Romano M, Coltorti M.
    Ital J Gastroenterol; 1993 Aug; 25(9):482-6. PubMed ID: 8123895
    [Abstract] [Full Text] [Related]

  • 17. [Viral hepatitis C].
    Zeuzem S, Roth WK, Herrmann G.
    Z Gastroenterol; 1995 Feb; 33(2):117-32. PubMed ID: 7536996
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prospective comparison of four lymphoblastoid interferon alpha schedules for chronic hepatitis C. A multivariate analysis of factors predictive of sustained response to treatment.
    Bellobuono A, Mondazzi L, Tempini S, Silini E, Idéo G.
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1169-77. PubMed ID: 9471022
    [Abstract] [Full Text] [Related]

  • 20. Serum HCV RNA levels in patients with chronic hepatitis C given a second course of interferon alpha-2b treatment after relapse following initial treatment.
    Weiland O, Zhang YY, Widell A.
    Scand J Infect Dis; 1993 Dec; 25(1):25-30. PubMed ID: 8384732
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.